Abiraterone Acetate Provided Significant Clinical Benefit in Patients with High-Risk Metastatic Hormone-Na ïve Prostate Cancer (mHNPC), Improving Overall Survival and Radiographic Progression-Free Survival

Source: Johnson and Johnson - Category: Pharmaceuticals Source Type: news